The Patent Finder
US

Process for the Preparation of Substituted Phenylalanines

US 7,855,291 In force, term unresolved
OverviewFamilyAssignmentsSources & methods
Collateral for a security interest recorded Apr 4, 2023 (Antares Capital LP).

Term ends no later than Apr 12, 2029 · Medium confidence

In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.

Filed Dec 28, 2006 as application 11/647,517 · Granted Dec 21, 2010
Base term plus 836 days of patent term adjustment (USPTO delay)
Today
20 years from filing
2006 2029
Clock starts
Dec 28, 2006
Ends no later than
Apr 12, 2029
Granted
Dec 21, 2010
base term patent term adjustment fee events Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
836
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Unresolved
Terminal disclaimer
On file, reference document not resolved, so the date above is an upper bound. We do not guess the cap.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term runs 836 days past its 20-year base term on prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. All three maintenance fees are recorded paid; no more fees are due. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Dec 28, 2006, when this application, 11/647,517, was filedDec 28, 2026High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+836 days, USPTO patent term adjustment recordApr 12, 2029High confidence
Terminal disclaimer capDisclaimer on file (approved), reference document not resolvedno cap applied, and none guessedMedium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events3 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderno later than Apr 12, 2029Medium confidence

This family

US 7,855,291this patent
no later than Apr 2029
no later than Apr 2029
US 7,897,763In force
Jan 2027
Jan 2027
US 8,450,532In force
Dec 2026
Dec 2026
Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Apr 2, 2007
Reel 19100, frame 97
Kanamarlapudi, Ramanaiah C.; Pickersgill, Iain Fraser; Shi, Zhi-cai; Wu, Wenxue; Zhang, Haiming; Burgoon, Hugh Alfred, JR.Lexicon Genetics IncorporatedAssignment of Assignor's Interest
Dec 20, 2017
Reel 44958, frame 377
Lexicon Pharmaceuticals, Inc.Biopharma Credit PLCSecurity Interest
Sep 9, 2020
Reel 53721, frame 37
Tersera Therapeutics LLCNewstone Capital Partners, LLCSecurity Interest
Sep 14, 2020
Reel 53767, frame 445
Biopharma Credit PLCLexicon Pharmaceuticals, Inc.Release of Security Interest
Sep 14, 2020
Reel 53763, frame 754
Lexicon Pharmaceuticals, Inc.Tersera Therapeutics LLCAssignment of Assignor's Interest
Sep 30, 2020
Reel 53940, frame 1
Tersera Therapeutics LLCMidcap Financial Trust, As AgentSecurity Interest
Apr 4, 2023
Reel 63215, frame 724
Tersera Therapeutics LLCAntares Capital LP, as AgentSecurity Interest
Apr 4, 2023
Reel 63221, frame 546
Newstone Capital Partners, LLCTersera Therapeutics LLC; JDP Therapeutics LLCRelease of Security Interest
Apr 4, 2023
Reel 63253, frame 942
Midcap Financial Trust, As AgentTersera Therapeutics LLCRelease of Security Interest
Apr 4, 2023
reel/frame not recorded
Newstone Capital Partners, LLCTersera Therapeutics LLCRelease of Security Interest
Apr 4, 2023
reel/frame not recorded
Newstone Capital Partners, LLCJDP Therapeutics LLCRelease of Security Interest
Apr 5, 2023
Reel 63227, frame 852
Tersera Therapeutics LLCNewstone Capital Partners, LLCSecurity Interest
Jan 7, 2025
Reel 69835, frame 704
Newstone Capital Partners, LLCTersera Therapeutics LLCRelease of Intellectual Property Security Agreement Recorded at R/F 63227/0852
Apr 15, 2026
Reel 75420, frame 453
Midcap Financial TrustTersera Therapeutics LLC,Release of Intellectual Property Security Agreements at R/F 41939/0487, 46591/0544 and 53940/0001

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited